Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone

European Journal of Pharmacology

Volumn 546, Issue 1-3, 2006, Pages 189-196

  Inagaki, Naoki ^a   Shiraishi, Noriko ^a   Igeta, Katsuhiro ^a   Itoh, Tomokazu ^a   Chikumoto, Takao ^a   Nagao, Masafumi ^a   Kim, John Fan ^a   Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Allergic dermatitis; Dexamethasone; Hapten; Immunoglobulin E; Interferon ; Interleukin 4; Interleukin 5; Mouse; Scratching behavior; Tacrolimus

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DERMIS; DRUG INHIBITION; DRUG MECHANISM; EPIDERMIS; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SCRATCHING; SKIN ALLERGY; SKIN INFLAMMATION;

ALLERGENS; ANESTHETICS, LOCAL; ANIMALS; ANTIPRURITICS; BEHAVIOR, ANIMAL; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DEXAMETHASONE; DIBUCAINE; DINITROFLUOROBENZENE; DISEASE MODELS, ANIMAL; GLUCOCORTICOIDS; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; NALOXONE; NARCOTIC ANTAGONISTS; PRURITUS; RNA, MESSENGER; SKIN; TACROLIMUS;

EID: 33748323235     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.07.019     Document Type: Article

References (41)

1. Barnetson R.S., and White A.D. The use of corticosteroids in dermatological practice. Med. J. Aust. 156 (1992) 428-431
2. Bavetta S., Hamlyn P.J., Burnstock G., Liberman A.R., and Anderson P.N. The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 158 (1999) 382-393
3. Bellinghausen I., Brand U., Enk A.H., Knop J., and Saloga J. Signals involved in the early TH1/TH2 polarization of an immune response depending on the type of antigen. J. Allergy Clin. Immunol. 103 (1999) 298-306
4. Bernstein J.E., Swift R.M., Soltani K., and Lorincz A.L. Antipruritic effect of an opiate antagonist, naloxone hydrochloride. J. Invest. Dermatol. 78 (1982) 82-83
5. Bieber T. Topical tacrolimus (FK 506): a new milestone in the management of atopic dermatitis. J. Allergy Clin. Immunol. 102 (1998) 555-557
6. Doran J.F., Jackson P., Kynoch P.A., and Thompson R.J. Isolation of PGP 9.5, a new human neurone-specific protein detected by high-resolution two-dimensional electrophoresis. J. Neurochem. 40 (1983) 1542-1547
7. Furue M., Furukawa F., Hide M., and Takehara K. Guidelines for therapy for atopic dermatitis 2004. Jpn. J. Dermatol. 114 (2004) 135-142
8. Hartung A.D., Bohnert A., Hackstein H., Ohly A., Schmidt K.L., and Bein G. Th2-mediated atopic disease protection in Th1-mediated rheumatoid arthritis. Clin. Exp. Rheumatol. 21 (2003) 481-484
9. Hirano T., Yamakawa N., Miyajima H., Maeda K., Takai S., Ueda A., Taniguchi O., Hashimoto H., Hirose S., Okumura K., and Ovary Z. An improved method for the detection of IgE antibody of defined specificity by ELISA using rat monoclonal anti-IgE antibody. J. Immunol. Methods 119 (1989) 145-150
10. Hoffman D.R., Yamamoto F.Y., Geller B., and Haddad Z. Specific IgE antibodies in atopic eczema. J. Allergy Clin. Immunol. 55 (1975) 256-267
11. Inagaki N., Nagao M., Nakamura N., Kawasaki H., Igeta K., Musoh K., and Nagai H. Evaluation of anti-scratch properties of oxatomide and epinastine in mice. Eur. J. Pharmacol. 400 (2000) 73-79
12. Inagaki N., Igeta K., Kim J.F., Nagao M., Shiraishi N., Nakamura N., and Nagai H. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur. J. Pharmacol. 448 (2002) 175-183
13. Inagaki N., Igeta K., Shiraishi N., Kim J.F., Nagao M., Nakamura N., and Nagai H. Evaluation and characterization of mouse scratching behavior by a new apparatus, MicroAct. Skin Pharmacol. Appl. Skin Physiol. 16 (2003) 165-175
14. Inoue M., Fujii Y., Furukawa K., Okada M., Okumura K., Hayakawa T., Furukawa K., and Sugiura Y. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside. J. Biol. Chem. 277 (2002) 29881-29888
15. Katayama I., Tanei R., Yokozeki H., Nishioka K., and Dohi Y. Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/c mice by monoclonal anti-DNP IgE antibody: possible implication for skin lesion formation in atopic dermatitis. Int. Arch. Allergy Appl. Immunol. 93 (1990) 148-154
16. Katoh N., Hirano S., Yasuno H., and Kishimoto S. Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis. J. Dermatol. 31 (2004) 194-199
17. Kitagaki H., Ono N., Hayakawa K., Kitazawa T., Watanabe K., and Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 159 (1997) 2484-2491
18. Kuraishi Y., Nagasawa T., Hayashi K., and Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275 (1995) 229-233
19. Leung A.K., and Barber K.A. Managing childhood atopic dermatitis. Adv. Ther. 20 (2003) 129-137
20. Lyons W.E., George E.B., Dawson T.M., Steiner J.P., and Snyder S.H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3191-3195
21. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio H., Ssito S., Askenase P.W., and Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9 (1997) 461-466
22. Matsuoka H., Maki N., Yoshida S., Arai M., Wang J., Ookawa Y., Ikeda T., Hirota N., Nakagawa H., and Ishii A. A mouse model of the atopic eczemw/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 58 (2003) 139-145
23. Metze D., Reimann S., Beissert S., and Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J. Am. Acad. Dermatol. 41 (1999) 533-539
24. Nagai H., Hiyama H., Matsuo A., Ueda Y., Inagaki N., and Kawada K. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. J. Pharmacol. Exp. Ther. 283 (1997) 321-327
25. Nagai H., Matsuo A., Hiyama H., Inagaki N., and Kawada K. Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten. J. Allergy Clin. Immunol. 100 (1997) S39-S44
26. Nakagawa H., Etoh T., Ishibashi Y., Higaki Y., Kawashima M., Torii H., and Harada S. Tacrolimus ointment for atopic dermatitis. Lancet 344 (1994) 883
27. Ray M.C., Tharp M.D., Sullivan T.J., and Tigelaar R.E. Contact hypersensitivity reactions to dinitrofluorobenzene mediated by monoclonal IgE anti-DNP antibodies. J. Immunol. 131 (1983) 1096-1102
28. Sampson H.A., and Albergo R. Comparison of results of prick skin tests, RAST, and double-blind placebo-controlled food challenges in children with atopic dermatitis. J. Allergy Clin. Immunol. 74 (1984) 26-33
29. Senba E., Katanosaka K., Yajima H., and Mizumura K. The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci. Res. 50 (2004) 257-262
30. Shuttleworth D., Hill S., Marks R., and Connelly D.M. Relief of experimentally induced pruritus with a novel eutectic mixture of local anaesthetic agents. Br. J. Dermatol. 119 (1988) 535-540
31. Singleton R.H., Stone J.R., Okonkwo D.O., Pellicane A.J., and Povlishock J.T. The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury. J. Neurotrauma 18 (2001) 607-614
32. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest. 101 (1998) 1614-1622
33. Stander S., and Luger T.A. Antipruritic effects of pimecrolimus and tacrolimus. Hautarzt 54 (2003) 413-417
34. Stander S., Moormann C., Schumacher M., Buddenkotte J., Artuc M., Shpacovitch V., Brzoska T., Lippert U., Henz B.M., Luger T.A., Metze D., and Steinhoff M. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp. Sermatol. 13 (2004) 129-139
35. Suto H., Matsuda H., Mitsuishi K., Hirai K., Uchida T., Unno T., Ogawa H., and Ra C. NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol. 120 (1999) 70-75
36. Tobin D., Nabarro G., Baart De La Faille H., Van Vloten W.A., Van Der Putte S.C., and Schuurman H.J. Increased number of immunoreactive nerve fibers in atopic dermatitis. J. Allergy Clin. Immunol. 90 (1992) 613-622
37. Urashima R., and Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch. 432 (1998) 363-370
38. Varreau A., Gueugnon J., Benavides J., and Vige X. Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons. Neuropharmacology 36 (1997) 1755-1762
39. Wahlgren C.F. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 47 (1992) 65-75
40. Wahlgren C.F. Itch and atopic dermatitis: an overview. J. Dermatol. 26 (1999) 770-779
41. Yokozeki H., Ghoreishi M., Takagawa S., Takayama K., Satoh T., Katayama I., Takeda K., Akira S., and Nishioka K. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 191 (2000) 995-1004